Rebastinib
2 mg
| Purity Not Available
TargetMol
DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
Macitentan
100 mg
| Purity Not Available
TargetMol
Macitentan is an endothelin receptor antagonist that is used in the therapy of pulmonary arterial hypertension (PAH).
More Information
Supplier Page
Pimecrolimus
100 mg
| Purity Not Available
TargetMol
Pimecrolimus, a calcineurin inhibitor immunosuppressant, binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin.
More Information
Supplier Page
Pimecrolimus
200 mg
| Purity Not Available
TargetMol
Pimecrolimus, a calcineurin inhibitor immunosuppressant, binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin.
More Information
Supplier Page
TargetMol
TargetMol
KN-62
100 mg
| 98.77%
TargetMol